Reuters logo
BRIEF-Moberg Pharma says agrees to acquire anesthetic spray DermoPlast
December 7, 2016 / 7:19 AM / a year ago

BRIEF-Moberg Pharma says agrees to acquire anesthetic spray DermoPlast

Dec 7 (Reuters) - Moberg Pharma AB (Publ)

* Says issues shares, secures acquisition financing and acquires DermoPlast

* Says entered into a definitive agreement to acquire DermoPlast for a purchase price of USD 47.6 mln plus stock value

* Says acquisition is financed through a directed new issue of shares in amount of SEK 148 mln, an issue of corporate bonds in amount of SEK 215 mln and by available cash resource

* Says DermoPlast is an anesthetic spray used externally for relief of pain and itching from skin chaps and skin injuries

* Says estimates that DermoPlast net sales was USD 12.0 mln, in the October 2015-September 2016 period, and an EBITDA of USD 5.4 mln

* Says purchase price corresponds to approximately 8.9 times the estimated EBITDA for DermoPlast for the equivalent period. Source text for Eikon: [ID:here ] Further company coverage: (Stockholm Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below